Randomized, Double-Blind, Vehicle-Controlled, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Phase of Trial: Phase II
Latest Information Update: 28 Dec 2017
At a glance
- Drugs Dapansutrile (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Olatec Therapeutics
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 May 2013 Planned number of patients changed from 66 to 84 as reported by ClinicalTrials.gov.
- 01 May 2013 Planned End Date changed from 1 Jun 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.